Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
- Call our CareLine:
- 800-886-ABTA (2282)
Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Glioblastomas, otherwise commonly known as GBMs, are malignant (cancerous) grade 4 tumors that affect the brain. Glioblastomas represent about 14% of all primary brain tumors and more than 12,000 glioblastoma cases are diagnosed each year in the United States. This half day meeting will focus on treatment advances and quality of life.
Chair: Yoshie Umemura, MD, MS
Chief of Neuro-Oncology, Chief Medical Officer of Ivy Brain Tumor Center
Barrow Neurological Institute
The need for better brain tumor treatments and more help for patients is greater than ever. Brain tumors are still very hard to treat because of something called the blood-brain barrier, which makes it tough for medicine to reach the tumor. Brain tumor patients need more options.
That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.
